CAS: 13292-45-0; N-Demethyl Rifampin

该化合物是麻黄素合成衍生物,一种以其抗菌感染,特别是结核病的功效而闻名的抗生素,一种具有抗菌素的合成衍生品;一种具有管子素的混合物,它能加强其药理特性,有可能提高其穿透细菌细胞壁和与RNA聚合酶互动的能力,从而抑制细菌RNA合成;管子杀菌素组的存在也可能有助于其溶解性和生物利用率;典型的情况是,氟虫素表现出广泛频谱抗菌活性,而这种复合物所见的改变可导致能量和活动范围的变化;此外,该化合物可能具有独特的药理学特性,影响其吸收,分布,代谢和排泄物;同许多抗生酶一样,培养抗药性是一个关键的考虑因素,需要不断研究其治疗抗菌菌株的功效和潜在应用.总体而言,3[(1-皮帕齐尼尼尼基尼基)甲基的叶酸盐是旨在加强抗生效的医学化学的一个显著例子.

结构式图片

MSDS等安全信息

    上下游产品

    piperazin-1-yl-amine 3-formylrifamycin SV

    合成工艺路线路线简述

      📜氨基哌嗪盐酸盐,3甲酰利福平霉素置于对甲苯磺酸体系中,用 四氢呋喃 用作溶剂,化学反应生成N-去甲利福平
      参考文献:Radiosynthesis And Bioimaging Of The Tuberculosis Chemotherapeutics Isoniazid,Rifampicin And Pyrazinamide In Baboons
      标题:Radiosynthesis And Bioimaging Of The Tuberculosis Chemotherapeutics Isoniazid,Rifampicin And Pyrazinamide In Baboons
      摘要:The Front-Line Tuberculosis (Tb) Chemotherapeutics Isoniazid (Inh),Rifampicin (Rif),And Pyrazinamide (Pza) Have Been Labeled With Carbon-11 And The Biodistribution Of Each Labeled Drug Has Been Determined In Baboons Using Positron Emission Tomography (Pet). Each Radiosynthesis And Formulation Has Been Accomplished In 1 H,Using [c-11]Ch3I To Label Rif And [c-11]Hcn To Label Inh And Pza. Following Iv Administration,Inh,Pza,Rif,And/or Their Radiolabeled Metabolites Clear Rapidly From Many Tissues; However,Inh,Pza,And/or Their Radiolabeled Metabolites Accumulate In The Bladder While Rif And/or Its Radiolabeled Metabolites Accumulates In The Liver And Gall Bladder,Consistent With The Known Routes Of Excretion Of The Drugs. In Addition,The Biodistribution Data Demonstrate That The Ability Of The Three Drugs And Their Radiolabeled Metabolites To Cross The Blood Brain Barrier Decreases In The Order Pza > Inh > Rif,Although In All Cases The Estimated Drug Concentrations Are Greater Than The Minimum Inhibitory Concentration (Mic) Values For Inhibiting Bacterial Growth Of Mycobacterium Tuberculosis (Mtb). The Pharmacokinetic (Pk) And Drug Distribution Data Have Important Implications For Treatment Of Disseminated Tb In The Brain And Pave The Way For Imaging The Distribution Of The Pathogen In Vivo.
      Doi:10.1021/jm901858N

      海关参考信息

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      合成参考文献


      摘要:Medoff G, Kwan CN, Schlessinger D, Kobayashi GS. Potentiation of rifampicin, rifampicin analogs, and tetracycline against animal cells by amphotericin B and polymyxin B. Cancer Res. 1973 Jun;33(6):1146–9.
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知